A single sublingual dose of an adenovirus-based vaccine protects against lethal ebola challenge in mice and guinea pigs

Jin Huk Choi, Stephen C. Schafer, Lihong Zhang, Gary P. Kobinger, Terry Juelich, Alexander N. Freiberg, Maria A. Croyle

Research output: Contribution to journalArticle

35 Scopus citations


Sublingual (SL) delivery, a noninvasive immunization method that bypasses the intestinal tract for direct entry into the circulation, was evaluated with an adenovirus (Ad5)-based vaccine for Ebola. Mice and guinea pigs were immunized via the intramuscular (IM), nasal (IN), oral (PO) and SL routes. SL immunization elicited strong transgene expression in and attracted CD11c(+) antigen presenting cells to the mucosa. A SL dose of 1 × 10 8 infectious particles induced Ebola Zaire glycoprotein (ZGP)-specific IFN-γ + T cells in spleen, bronchoalveolar lavage, mesenteric lymph nodes and submandibular lymph nodes (SMLN) of naive mice in a manner similar to the same dose given IN. Ex vivo CFSE and in vivo cytotoxic T lymphocyte (CTL) assays confirmed that SL immunization elicits a notable population of effector memory CD8+ T cells and strong CTL responses in spleen and SMLN. SL immunization induced significant ZGP-specific Th1 and Th2 type responses unaffected by pre-existing immunity (PEI) that protected mice and guinea pigs from lethal challenge. SL delivery protected more mice with PEI to Ad5 than IM injection. SL immunization also reduced systemic anti-Ad5 T and B cell responses in naive mice and those with PEI, suggesting that secondary immunizations could be highly effective for both populations.

Original languageEnglish (US)
Pages (from-to)156-167
Number of pages12
JournalMolecular Pharmaceutics
Issue number1
StatePublished - Jan 1 2012



  • CD4 T cell
  • Ebola Zaire
  • adenovirus 5
  • guinea pig
  • memory response
  • mouse
  • pre-existing immunity
  • sublingual
  • toxicity
  • vaccine

ASJC Scopus subject areas

  • Molecular Medicine
  • Pharmaceutical Science
  • Drug Discovery

Cite this